Skip to main content

CSL

CSL is a publicly listed biotechnology company headquartered in Australia. Founded in 1916, CSL develops and delivers biotherapies and vaccines that address serious diseases such as haemophilia, immune deficiencies, kidney disorders, and influenza. Its main businesses, CSL Behring, CSL Seqirus, and CSL Vifor, focus on innovative therapies and vaccines. CSL operates globally across multiple regions, is listed in the Forbes Global 2000.

East Asia & Pacific
Pharmaceuticals & Biotechnology
Public
Not Engaged
Visit Website
ACT Core
E Committed but not planning
Just Transition
0.0/100
Nature Benchmark
14.3/100
Social Benchmark
29.6/100
Gender Assessment
26.2/100
On this page

Subscribe to stay informed on our work

Keep up to date with all the latest from World Benchmarking Alliance

Join our newsletter